Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.235

-3.5%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Savant	3/14/2025 11:16:44 AM
	of 3576

ATLANTA, March 14, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Geron Corporation (“Geron” or the “Company”) (NASDAQ: GERN). The lawsuit alleges that Defendants disseminated materially false and misleading statements and/or concealed material adverse facts concerning Rytelo’s (imetelstat) potential. If you bought shares of Geron between June 7, 2024 and February 25, 2025, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights globenewswire.com =============================== Merck diversity leader to retire this summer; Geron seeks commercial chops for next CEO pharmaceuticals.einnews.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next